Arcutis CMO sells $30,047 in shares for taxes
Alpha Vantage · Investing.com · · AI-summarised by FinFlash
Patrick Burnett, EVP and CMO of Arcutis Biotherapeutics, sold 943 shares worth $30,047 to cover tax obligations on vested restricted stock units. The sale comes as shares trade near a 52-week high, up 45% over six months, with InvestingPro flagging the stock as slightly overvalued. Q3 2026 results beat revenue estimates on ZORYVE demand but missed profit forecasts.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.